Back to search

University of British Columbia

Predicting sustained remission and maximal disease severity in pediatric Crohn's disease using machine learning

Abstract

dc:description

Crohn's disease (CD) is a chronic inflammatory condition affecting the gastrointestinal tract, and displays a growing prevalence in children. In affected children, it displays more heterogeneous disease trajectories and treatment responses than adult-onset cases, posing significant management challenges. While early aggressive treatment may benefit patients with severe trajectories, no objective method exists to identify the high-risk children at diagnosis. This prognostic gap forces reliance on subjective clinical judgment, potentially delaying critical interventions. This study aimed to use machine learning models to predict two first-year outcomes in the Canadian Children IBD Network inception cohort: 1) sustained remission vs non-sustained remission, defined as maintaining a post-remission Weighted Pediatric Crohn's Disease Activity Index (wPCDAI) <12.5 without inflammatory episodes, and 2) maximal disease severity (remission/mild [post-diagnosis wPCDAI <40, indicating minimal inflammatory activity] vs moderate/severe [wPCDAI ≥40, indicating substantial inflammation and need for treatment escalation]). Nine algorithms were trained on baseline clinical, microbiome, and integrated clinical-microbiome datasets using repeated nested 3-fold cross-validation, with the minimum redundancy maximal relevance feature selection, Bayesian hyperparameter optimization, and SHAP for model explainability. For sustained remission prediction, integrated models outperformed microbiome- or clinical-only models, with integrated logistic regression achieving the highest mean AUC (0.763); key features included initial treatment at diagnosis, disease location, and wPCDAI at diagnosis, as well as taxa known to play a role in CD such as Haemophilus and Lachnospiraceae. For maximal disease severity prediction, microbiome models performed best, with Gaussian naïve Bayes reaching a mean AUC of 0.801 and highlighting microbes such as Clostridium and Veillonella as predictors of severe disease, while taxa such as Coprococcus and Romboutsia were associated with milder disease. Bayesian decision curve analysis of our top-performing models also demonstrated likely clinical utility at relevant decision thresholds. Our results suggest the potential of integrated machine learning approaches to support clinical decision-making in pediatric Crohn's disease. By enabling early identification of high-risk patients at diagnosis, this work paves the way for personalized treatment strategies that could improve long-term outcomes in this vulnerable population.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ng, Irvin
Contributors dc:contributor
  • Korthauer, Keegan
  • Vallance, Bruce A.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/93883

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ng, Irvin. Predicting sustained remission and maximal disease severity in pediatric Crohn's disease using machine learning. master's thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/93883